Skip to content
10-Q

Quarterly Report

Raphael Pharmaceutical Inc. RAPH

0001213900-25-075662

← back to feed
Filed
Aug 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 12, 2025 19.63M sh
Shares Diluted Q2 2025 · Jun 30, 2025 19.63M sh
Shares Diluted Q2 2025 · Jun 30, 2025 19.37M sh
Shares Diluted Q2 2025 · Jun 30, 2024 18.68M sh
Shares Diluted Q2 2025 · Jun 30, 2024 18.65M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$239K
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$390K
Cash And Equivalents Q2 2025 · Jun 30, 2025 $20K
Cash And Equivalents Q2 2025 · Dec 31, 2024 $19K
Stockholders Equity Q2 2025 · Jun 30, 2025 −$1.05M
Stockholders Equity Q2 2025 · Mar 31, 2025 −$734K
Stockholders Equity Q2 2025 · Dec 31, 2024 −$742K
Stockholders Equity Q2 2025 · Jun 30, 2024 −$290K
Stockholders Equity Q2 2025 · Mar 31, 2024 −$103K
Stockholders Equity Q2 2025 · Dec 31, 2023 $267K
Current Liabilities Q2 2025 · Jun 30, 2025 $1.08M
Current Liabilities Q2 2025 · Dec 31, 2024 $769K
Current Assets Q2 2025 · Jun 30, 2025 $28K
Current Assets Q2 2025 · Dec 31, 2024 $25K
Total Assets Q2 2025 · Jun 30, 2025 $30K
Total Assets Q2 2025 · Dec 31, 2024 $27K
Eps Diluted Q2 2025 · Jun 30, 2025 $0.02
Eps Diluted Q2 2025 · Jun 30, 2025 $0.04
Eps Diluted Q2 2025 · Jun 30, 2024 $0.01
Eps Diluted Q2 2025 · Jun 30, 2024 $0.04
Eps Basic Q2 2025 · Jun 30, 2025 $0.02
Eps Basic Q2 2025 · Jun 30, 2025 $0.04
Eps Basic Q2 2025 · Jun 30, 2024 $0.01
Eps Basic Q2 2025 · Jun 30, 2024 $0.04
Sga Expense Q2 2025 · Jun 30, 2025 $174K
Sga Expense Q2 2025 · Jun 30, 2025 $527K
Sga Expense Q2 2025 · Jun 30, 2024 $225K
Sga Expense Q2 2025 · Jun 30, 2024 $393K
Rd Expense Q2 2025 · Jun 30, 2025 $141K
Rd Expense Q2 2025 · Jun 30, 2025 $213K
Rd Expense Q2 2025 · Jun 30, 2024 $24K
Rd Expense Q2 2025 · Jun 30, 2024 $403K
Net Income Q2 2025 · Jun 30, 2025 −$322K
Net Income Q2 2025 · Jun 30, 2025 −$751K
Net Income Q2 2025 · Mar 31, 2025 −$429K
Net Income Q2 2025 · Jun 30, 2024 −$248K
Net Income Q2 2025 · Jun 30, 2024 −$798K
Net Income Q2 2025 · Mar 31, 2024 −$550K
Operating Income Q2 2025 · Jun 30, 2025 −$315K
Operating Income Q2 2025 · Jun 30, 2025 −$740K
Operating Income Q2 2025 · Jun 30, 2024 −$249K
Operating Income Q2 2025 · Jun 30, 2024 −$796K